[COX-2 and HO-1 Are Involved in the Delayed Preconditioning Elicited by Bradykinin in Rat Hearts].

Hai-Zheng Dong,Ying-Ying Chen,Li Zhu,He-Jing Xu,Yang Wang,Fa-Rong Shen,Zhu-Nan Cai,Yue-Liang Shen
DOI: https://doi.org/10.3785/j.issn.1008-9292.2007.01.003
2007-01-01
Abstract:OBJECTIVE:To investigate whether cyclooxygenase-2 (COX-2) and heme oxygenase-1 (HO-1) are involved in the bradykinin-induced delayed protection.METHODS:Cardiac contractility, lactate dehydrogenase (LDH) and infarct area were analyzed in isolated rat hearts undergoing ischemia-reperfusion injury induced by Langendorff method.RESULT:Conscious rats received bradykinin (40 microg/kg), and the isolated hearts were subjected to 30 min of regional ischemia and 120 min of reperfusion 24 h later. Bradykinin pretreatment would improve post-ischemic performance, and reduced the release of LDH and infarct size. COX-2 inhibitor celecoxib (3 mg/kg) abolished bradykinin-induced protection, leading to poorer myocardial performance, release of more LDH and larger infarct sizes. Administration of HO-1 inhibitor ZnPP IX(20 microg/kg) before bradykinin partially abrogated the delayed protection. Pretreatment with the mitochondrial ATP sensitive potassium channel(mitoK(ATP) antagonist 5-HD before or 24 h after bradykinin administration also abolished the effect of protection.CONCLUSION:The results indicate that activation of HO-1 and COX-2 might be involved in the delayed cardioprotection evoked by bradykinin, and mitoK(ATP) channel may serve as both a trigger and a mediator in the cardioprotection.
What problem does this paper attempt to address?